Oxidation process for preparing 3-formyl-cephem derivatives

ABSTRACT

The present invention relates to an improved process for oxidizing 3-hydroxy-methyl-cephem derivatives to the corresponding 3-formyl-cephem derivatives. In particular this oxidation process is for the preparation of 7-[2-(5-amino-[1,2,4]thia-diazol-3-yl)-2-hydroxyimino-acetylamino]-3-formyl-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid derivatives of formula (I) using a combination of a hypervalent iodine oxidizing agent of the type 10-I-3 such as bis(acetoxy)iodo-benzene (BAIB) and a catalyst such as 2,2,6,6-tetramethyl-1-piperidinyloxy (TEMPO). These compounds of formula (I) are intermediates in the synthesis of ceftobiprole.

This application is a National Stage Application of PCT/EP2011/057404filed May 9, 2011, which claims priority from European PatentApplication 10162407.0 filed on May 10, 2010. The priority of both saidPCT and European Patent Application are claimed.

BACKGROUND OF THE INVENTION

The present invention relates to an improved process for oxidizing3-hydroxy-methyl-cephem derivatives to the corresponding 3-formyl-cephemderivatives. In particular this oxidation process is for the preparationof7-[2-(5-amino-[1,2,4]thia-diazol-3-yl)-2-hydroxyimino-acetylamino]-3-formyl-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylicacid derivatives of formula (I) using a combination of a hypervalentiodine oxidizing agent of the type 10-I-3 such asbis(acetoxy)iodo-benzene (BAIB) and a catalyst such as2,2,6,6-tetramethyl-1-piperidinyloxy (TEMPO). These compounds of formula(I) are intermediates in the synthesis of ceftobiprole.

Compounds of formula (I) and methods for preparing these compounds havebeen disclosed in WO-01/90111. WO-01/90111 also discloses a process forthe preparation of ceftobiprole. Other methods for the preparation ofceftobiprole are disclosed in WO-99/65920 and Drugs of the Future,30(1), p. 11-22 (2005).

Ceftobiprole is a parenterally administered cephalosporin with highaffinity for most penicillin-binding proteins, including the mecAproduct penicillin binding protein (PBP) 2a, rendering it active againstmethicillin-resistant Staphylococcus aureus (MRSA). Ceftobiprole showsbroad-spectrum activity against relevant resistant Gram-positive andGram-negative pathogens in vitro and has a low liability to induceresistance. It is administered in vivo as a water soluble prodrug,ceftobiprole medocaril, which is rapidly cleaved in plasma to formceftobiprole, diacetyl and CO₂. The chemical structure of ceftobiproleand ceftobiprole medocaril are shown below.

WO-01/90111 discloses two oxidation procedures (Example 2 on page 16)for oxidizing 3-hydroxy-methyl-cephem derivatives of formula (II) to thecorresponding 3-formyl-cephem derivatives of formula (I):

The first oxidation procedure disclosed in WO-01/90111 uses a mixture ofan inorganic hypohalite such as sodium hypochlorite and2,2,6,6-tetramethyl-1-piperidinyloxy (TEMPO) whereby the reactionmixture is a two-phase mixture of water and dichloromethane that isvigorously stirred. Substituent R¹ is a hydroxy protecting group(triphenylmethyl group) and R² is a carboxylic acid protecting group,(diphenylmethyl). The reported yield is 74%.

The second oxidation procedure disclosed in WO-01/90111 uses MnO₂ as theoxidizing agent suspended in a mixture of tetrahydrofuran anddichloromethane. The reported yield is 52%.

In general the present invention concerns the oxidation of a primaryalcohol to an aldehyde using an oxidizing agent. A number of art knownoxidizing agents are known such as Jones reagent (chromic acid andsulfuric acid in water), Collins reagent (dipyridine Cr(VI) oxide),Dess-Martin periodinane, pyridinium chlorochromate (PCC), pyridiniumdichromate (PDC), MnO₂, o-iodoxy benzoic acid (IBX), methyl-2-iodoxybenzoate, isopropyl-2-iodoxy benzoate,trichloro isocyanuric acid, and acombination of TEMPO with an inorganic hypochlorite. The selection ofthe most suitable oxidizing agent is a cumbersome process wherein issuessuch as over-oxidation to a carboxylic acid, yield, impurities, cost,reaction time, scale-up possibilities, and the like have to be evaluatedin order to achieve the best results.

The oxidation procedures to convert 3-hydroxymethyl-cephem derivativesof formula (II) to the corresponding 3-formyl-cephem derivatives offormula (I) as disclosed in WO-01/90111 (Example 2 on page 16) have thefollowing disadvantages:

-   -   low yield: 52% when MnO₂ is used    -   low yield: 74% when a combination of sodium hypochlorite and        TEMPO as oxidizing agent is used    -   sodium hypochlorite needs to be carefully dosed in a continuous        way to minimise over-oxidation (formation of S-oxides)    -   heterogeneous two-phase system of water and dichloromethane that        needs to be stirred vigorously    -   large volume of solvent is needed: about 7.6 litre/mol.

SUMMARY OF THE INVENTION

It has now been found that the above mentioned disadvantages for theoxidation of 3-hydroxymethyl-cephem derivatives of formula (II) to thecorresponding 3-formyl-cephem derivatives of formula (I) can be overcomewhen using a combination of a hypervalent iodine oxidizing agent of thetype 10-I-3 such as bis(acetoxy)iodobenzene (BAIB) and a catalyst as2,2,6,6-tetramethyl-1-piperidinyloxy (TEMPO). This oxidation system usesa catalytic amount of TEMPO ranging from 0.05 mol to 0.2 mol and aslight excess of BAIB in an amount from 1 mol to 1.2 mol. BAIBregenerates the TEMPO that is being consumed during the oxidationreaction in order to close the catalytic cycle. This oxidation procedurehas the following advantages:

-   -   improved yield : up to 84%    -   improved purity ranging from 92.8 to 97.9% (purity measured        using LC), compared to a purity of 83 to 92% when the above        mentioned procedure from the prior art was reproduced in-house    -   no issues with addition rate of the oxidizing agent and no        over-oxidation, thereby resulting in higher product quality    -   one organic phase and therefore no need for vigorous stirring,        therefore easier and more robust to scale-up    -   lower volume of solvent used: 2 to 5 litre/mol.

DETAILED DESCRIPTION OF THE INVENTION

The present invention concerns a process for the preparation of a7-[2-(5-amino-[1,2,4]thiadiazol-3-yl)-2-hydroxy-imino-acetylamino]-3-formyl-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylicacid derivative of formula (I)

wherein R¹ is a hydroxy protecting group and R² is a carboxylic acidprotecting group, which process is characterized in that it comprisesoxidizing a compound of formula (II)

with a combination of a hypervalent iodine oxidizing agent of the type10-I-3 such as bis(acetoxy)iodo-benzene (BAIB) or[bis(1,1,1-trifluoroacetoxy)iodo]benzene (BTIB) and a catalyst selectedfrom 2,2,6,6-tetramethyl-1-piperidinyloxy (TEMPO),4-hydroxy-2,2,6,6-tetramethyl-1-piperidinyloxy and 4-(acetylamino)-2,2,6,6-tetramethyl-1-piperidinyloxy in a suitable solvent.

The term “hydroxy protecting group” as used herein defines a protectinggroup which is generally used to replace a hydrogen of the hydroxylgroup. Examples of such a group is e.g. benzyl, phenylethyl,naphthalenylmethyl, triphenylmethyl, or a tri(C₁₋₆alkyl)silyl such ase.g. trimethylsilyl, or tert-butyl-dimethylsilyl. A commonly usedhydroxy protecting group is a triphenylmethyl group (also called atrityl group).

The term “carboxylic acid protecting group” as used herein defines aprotecting group which is generally used to replace a hydrogen of thecarboxyl group. Examples of such a group is e.g. diphenylmethyl,tert-butyl, p-nitrobenzyl, p-methoxy-benzyl, methoxymethyl and the like.Diphenylmethyl is a commonly used carboxylic acid protecting group.

The term “C₁₋₆alkyl” as used herein defines straight and branched chainsaturated hydrocarbon radicals having from 1 to 6 carbon atoms such as,for example, methyl, ethyl, propyl, butyl, 1-methylethyl,2-methylpropyl, 2-methylbutyl, pentyl, hexyl and the like.

Hypervalent iodine oxidizing agent of the type 10-I-3 have beendescribed by De Mico A. et al. in J. Org. Chem., 62, 6974-6977 (1997)such as bis(acetoxy)iodo-benzene (BAIB) or[bis(1,1,1-trifluoroacetoxy)iodo]benzene (BTIB).

The amount of catalyst selected from2,2,6,6-tetramethyl-1-piperidinyloxy (TEMPO),4-hydroxy-2,2,6,6-tetramethyl-1-piperidinyloxy and4-(acetylamino)-2,2,6,6-tetramethyl-1-piperidinyloxy ranges between 0.05and 0.2 mol with respect to the compound of formula (II) and the amountof hypervalent iodine oxidizing agent of the type 10-I-3 ranges between1 mol and 1.2 mol with respect to the compound of formula (II). Inpractice the amount of catalyst is usually 0.1 mol and the amount ofhypervalent iodine oxidizing agent of the type 10-I-3 is 1.1 mol withrespect to the compound of formula (II).

Suitable solvents for use in the oxidation process of the presentinvention are selected from halogenated hydrocarbons such asdichloromethane; esters such as ethyl acetate; ethers such astetrahydrofuran; hydrocarbons such as toluene; polar solvents such asacetone and acetonitrile; and solvent mixtures thereof, such as solventmixtures of dichloromethane with tetrahydrofuran, acetonitrile, orethylacetate, solvent mixtures of ethyl acetate with tetrahydrofuran,and solvent mixtures of toluene with tetrahydrofuran.

EXAMPLES

Experimental Part

General Oxidation Procedure

-   -   1 mol of        7-[2-(5-amino-[1,2,4]thiadiazol-3-yl)-2-trityloxyimino-acetylamino]-3-hydroxymethyl-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic        acid benzhydryl ester (compound 2) was added to a reaction        vessel    -   solvent was added and cooled to 10° C.    -   0.10 mol of catalyst selected from        2,2,6,6-tetramethyl-1-piperidinyloxy (TEMPO),        4-hydroxy-2,2,6,6-tetramethyl-1-piperidinyloxy and        4-(acetylamino)- 2,2,6,6-tetramethyl-1-piperidinyloxy was added    -   stirred for another 5 minutes    -   1.1 mol of a hypervalent iodine oxidizing agent of the type        10-I-3 selected from bis(acetoxy)iodo-benzene (BAIB) was added    -   stirred till complete conversion (as measured by LC)    -   work-up procedure:        -   the reaction product was precipitated by the addition of an            anti-solvent such as cyclohexane (other suitable            anti-solvents are methylcyclohexane, isooctane,            diisopropylether and cyclopentylmethylether)        -   precipitate was filtered off        -   precipitate was washed        -   isolated            7-[2-(5-amino-[1,2,4]thiadiazol-3-yl)-2-trityloxyimino-acetylamino]-3-formyl-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic            acid benzhydryl ester (compound (1)) was dried at 30° C.            under vacuum            Results: catalyst is TEMPO            (2,2,6,6-tetramethyl-1-piperidinyloxy) and hypervalent            iodine oxidizing agent of the type 10-I-3 is BAIB

TEMPO BAIB purity of isolated yield solvent # eq. # eq compound 1 mol %CH₂Cl₂ (10 L/mol)  0.1 mol  1.1 mol 95.6% 81.1 CH₂Cl₂ (5 L/mol)  0.1 mol 1.1 mol 96.1% 81.9 ethylacetate (5 L/mol)  0.1 mol  1.1 mol 95.3% 58.2THF (2 L/mol)  0.1 mol  1.1 mol 96.3% 72.7 acetonitril (3 L/mol)  0.1mol  1.1 mol 97.9% 64.2 CH₂Cl₂/THF  0.1 mol  1.1 mol 93.2% 83.9 (2L/mol/1 L/mol) CH₂Cl₂/acetonitril 0.05 mol  1.1 mol 95.6% 81.7 (2.5L/mol/0.5 L/mol) CH₂Cl₂/acetonitril 0.05 mol 1.05 mol 92.8% 78.1 (2.25L/mol/0.75 L/mol)

The invention claimed is:
 1. A process for the preparation of7-[2-(5-amino-[1,2,4]thiadiazol-3-yl)-2-hydroxy-imino-acetylamino]-₃-formyl-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylicacid derivative of formula (I)

wherein R¹ is a hydroxyl protecting group and R² is a carboxylic acidprotecting group, which process is characterized in that it comprisesoxidizing a compound of formula (II)

with a combination of a hypervalent iodine oxidizing agent of the type10-I-3 and a catalyst selected from 2,2,6,6-tetramethyl-1-piperidinyloxy(TEMPO), 4-hydroxy-2,2, 6,6-tetramethyl-1-piperidinyloxy and4-(acetylamino)- 2,2,6,6-tetramethyl-1-piperidinyloxy in a solventselected from the group consisting of dichloromethane, mixtures ofdichloromethane and tetrahydrofurane and mixtures of dichloromethane andacetonitrile.
 2. The process as claimed in claim 1 wherein thehypervalent iodine oxidizing agent is selected frombis(acetoxy)iodobenzene (BAIB) or [bis(1,1,1-trifluoroacetoxy)-iodo]benzene (BTIB).
 3. The process as claimed in claim 2 wherein thehypervalent iodine oxidizing agent is bis(acetoxy)iodobenzene (BAIB). 4.The process as claimed in claim 3 wherein the hydroxyl protecting groupR¹ is selected from benzyl, phenylethyl,naphthalenylmethyl,triphenylmethyl, or a tri(C₁₋₆alkyl)silyl, and thecarboxylic acid protecting group R² is selected from diphenylmethyl,tert-butyl, p-nitrobenzyl, p-methoxybenzyl, methoxymethyl.
 5. Theprocess as claimed in claim 4 wherein R¹ is triphenylmethyl and R² isselected from diphenylmethyl.
 6. The process as claimed in claim 5wherein the catalyst is 2,2,6,6-tetramethyl -1-piperidinyloxy (TEMPO).7. The process as claimed in claim 5 wherein the amount of catalystranges between 0.05 and 0.2 mol with respect to the compound of formula(II) and the amount of BAIB ranges between 1 mol and 1.2 mol withrespect to the compound of formula (II).
 8. The process as claimed inclaim 7 wherein the amount of catalyst is 0.1 mol and the amount of BAIBis 1.1 mol with respect to the compound of formula (II).
 9. The processas claimed in claim 6 wherein the amount of catalyst ranges between 0.05and 0.2 mol with respect to the compound of formula (II) and the amountof BAIB ranges between 1 mol and 1.2 mol with respect to the compound offormula (II).